For laboratory research use only — not for human or veterinary consumption.
The Peptide Index
Dosing guide

MOTS-c Dosage Chart & Schedule

A mitochondrial-derived peptide studied as a metabolic regulator and exercise-mimetic in preclinical models, and of interest in aging and insulin-sensitivity research.

Route
Subcutaneous
Frequency
1-2x weekly
Half-life
Short systemically
Storage
Refrigerate reconstituted; keep lyophilized cool + dark
The short answer

A mitochondrial-derived peptide with no established human dosing. Research-community references commonly land in a roughly 5-10 mg per week range, often split across one or two subcutaneous injections.

Figures describe how MOTS-c is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.

Dosage protocols

Commonly referenced research tiers. Start conservative; every compound and study context differs.

Starter
5 mg
per injection
Frequency
Once weekly
Weekly total
5 mg
Cycle
Cycled (e.g., 4-6 weeks)

Lower end of the commonly referenced weekly range, given as a single injection.

Most commonStandard
5 mg
per injection
Frequency
Twice weekly
Weekly total
10 mg
Cycle
Cycled (e.g., 4-6 weeks)

Upper end of the referenced range, split into two injections; human dosing remains unestablished.

Preclinical, not established in humans

  • Studied mainly in animal and cell models as a metabolic regulator and exercise-mimetic acting via the AMPK energy-sensing pathway.
  • Short systemic presence is why references favor intermittent (a few times weekly) rather than continuous dosing.
  • There is no established human clinical dose; figures are research-community references only.

Ready to run this protocol?

Dosing is only as good as the vial. MOTS-c is third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.

Weekly schedule

A typical week on the standard protocol (Twice weekly).

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Dosing day Off

MOTS-c reconstitution

Based on a standard 10 mg vial: with 2 mL bacteriostatic water = 5,000 mcg/mL (5 mg/mL); 1 unit ≈ 50 mcg.

Concentration
5,000 mcg/mL
Per syringe unit
50 mcg
Draw for 5 mg
100 units
Doses per vial
~2
Open this mix in the calculator →

From vial to injection in 6 steps

1

Wipe both vial tops

Swab the peptide vial and the bacteriostatic-water vial with fresh alcohol and let them dry.

2

Draw the water

Pull the planned amount of bacteriostatic water (2 mL) into the syringe.

3

Add it slowly

Run the water down the inside wall of the vial — don't blast the powder. Swirl gently; never shake.

4

Let it dissolve

Wait until the solution is fully clear, then refrigerate the vial.

5

Draw your dose

Pull the calculated units on a U-100 insulin syringe (~100 units for 5 mg).

6

Store between uses

Keep the reconstituted vial refrigerated and use within its stable window.

Handling & storage

  • A 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL, so a 5 mg dose is 1 mL - a full U-100 syringe.
  • Reconstituting the 10 mg vial with 1 mL instead gives 10 mg/mL, halving the injection volume (5 mg = about 50 units).
  • Refrigerate after reconstitution and keep the lyophilized powder cool and dark.

MOTS-c dosing FAQ

How often is MOTS-c dosed?

Its short systemic presence leads references to favor intermittent dosing - commonly one to two times weekly rather than daily - with a weekly total often cited around 5-10 mg.

Is there an established human dose?

No. Most evidence is preclinical, so any figure is a research-community reference rather than a validated human protocol.

How do I keep the shot volume reasonable?

At 5 mg/mL a 5 mg dose is a full 1 mL syringe; mixing the 10 mg vial with 1 mL of water (10 mg/mL) cuts that to about 0.5 mL, or the dose can be split across two injections.

Sources

Categories: Longevity & Cellular, GLP-1 & Metabolic · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.